PVRIG and neoplasm: Taken together, our results demonstrated that anti-hPVRIG mAb in vitro enhanced the cytotoxicity of human NKG cells, purified NK cells and PBMCs against human tumor cells and, further, significantly inhibited tumor growth in human NK cell- or PBMC-reconstituted xenograft mice, suggesting the potential value of PVRIG blockade in translational applications.